abstract |
Compounds possessing the formula (I) or (II) wherein R1, R2, B, and V as defined herein are inhibitors of the hepatitis C virus NS5b polymerase. Compositions and methods for the treatment of an HCV infection and that inhibit HCV replication. (see formulas). |